Owen Hughes
Chief Executive Officer at XOMA ROYALTY CORPORATION
Net worth: 133 635 $ as of 2024-06-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Anthony Adam Rosenberg | M | 71 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 9 years |
George Martin | M | 65 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 9 years |
William Irving | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. The firm also sub-advices funds or accounts for affiliated advisers and unaffiliated advisers. | 18 years |
Nadim Ahmed | M | 56 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 3 years |
Mark Manfredi | M | 53 | 8 years | |
Jean-Francois Formela | M | 67 | 13 years | |
Stephen Webster | M | 63 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 4 years |
Steven Helwig | M | 51 | 9 years | |
Kendra Adams | F | 47 | 4 years | |
Michael Jarasitis | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. The firm also sub-advices funds or accounts for affiliated advisers and unaffiliated advisers. | 18 years |
Jennifer Michaelson | M | 57 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 6 years |
Andrew von Eschenbach | M | 82 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 5 years |
Samuel Cohen | M | 38 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 years |
Kenneth Anderson | M | 72 | 9 years | |
Andrew Hirsch | M | 53 | 4 years | |
Richard Wooster | M | 59 | 5 years | |
Jack Wyszomierski | M | 68 | 14 years | |
Bihua Chen | F | 55 | 9 years | |
William Daniel | M | 72 | 9 years | |
Bruce Downey | M | 76 | 9 years | |
Utpal Koppikar | M | 53 | 2 years | |
Maria Koehler | M | 67 | 3 years | |
Laura Bessen | M | 61 | 2 years | |
Malcolm Salter | M | 84 | 9 years | |
Michele Vendruscolo | F | 58 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 years |
Christopher Dobson | M | 75 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 years |
Bruce Mitlak | M | - | 8 years | |
Corinne Savill | M | 64 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 years |
Jolie Siegel | F | 48 | 4 years | |
Chhaya Shah | F | 60 | 6 years | |
Heather Franklin | F | 58 | 3 years | |
Thomas Burns | M | 50 | 18 years | |
Natasha Hernday | F | 52 | 4 years | |
Joseph Limber | M | 71 | 12 years | |
Mark Schmehl | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. The firm also sub-advices funds or accounts for affiliated advisers and unaffiliated advisers. | 17 years |
Dan Tremblay | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. The firm also sub-advices funds or accounts for affiliated advisers and unaffiliated advisers. | 18 years |
Charles Ackerman | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. The firm also sub-advices funds or accounts for affiliated advisers and unaffiliated advisers. | 18 years |
David Bonita | M | 48 | 8 years | |
Otello Stampacchia | M | 55 | 4 years | |
Jean-Michel Cossery | M | 65 | 6 years | |
Matthew Perry | M | 51 | 7 years | |
Barbara Kosacz | F | 66 | 5 years | |
Donna Grogan | M | 67 | 2 years | |
Iain Dukes | M | 65 | 8 years | |
Peter A. Schwartzman | M | - | 4 years | |
Rudy Mareel | M | 61 | 6 years | |
Jeffrey Ecsedy | M | 54 | 7 years | |
Salvador Grausso | M | 49 | 4 years | |
Stephanie Torruella | F | - | 4 years | |
Joan Gray | F | - | 3 years | |
Samantha Vuksanic | F | - | 3 years | |
Rupert Haynes | M | - | 3 years | |
Laura Furmanski | F | - | 2 years | |
Cole Ikkala | M | - | 4 years | |
Travis Wilson | M | - | 2 years | |
Jotin Marango | M | 45 | 2 years | |
Fiona Dunlevy | F | 41 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | - |
César Hernández | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. The firm also sub-advices funds or accounts for affiliated advisers and unaffiliated advisers. | 18 years |
Mark Mossler | M | 51 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ronald Renaud | M | 55 | 8 years | |
Ansbert Gadicke | M | 66 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 11 years |
Young Duchung Chin | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. The firm also sub-advices funds or accounts for affiliated advisers and unaffiliated advisers. | 7 years |
Raymond T. Keane | M | 65 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | 9 years |
Patrick Baeuerle | M | 66 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 years |
James Neal | M | 68 | 14 years | |
Thomas Ebeling | M | 65 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 years |
Daniel Dolan | M | 47 | 4 years | |
Michael Wyzga | M | 69 | 2 years | |
Michael Heartlein | M | 65 | 9 years | |
Adrian Howd | M | 52 | 3 years | |
Jesper Høiland | M | 63 | 3 years | |
James Chopas | M | 57 | 3 years | |
Andrew Fromkin | M | 58 | - | |
Paul Burgess | M | 50 | 6 years | |
Jon Wigginton | M | 62 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 2 years |
Darragh Lyons | M | 43 | 8 years | |
Donal O'Connor | M | 73 | 1 years | |
Robert E. Ward | M | 66 | 4 years | |
John Schroer | M | 58 | 2 years | |
Anderson Timothy | M | - |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 2 years |
Averi Price | F | - | 6 years | |
Brian Harvey | M | 63 | 11 years | |
Mark Conley | M | 62 | 1 years | |
Brent Hatzis-Schoch | M | 59 | 4 years | |
Morana Jovan-Embiricos | M | 57 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 years |
Kyran McLaughlin | M | 80 | 2 years | |
Jeffrey Trigilio | M | 40 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 4 years |
Erick Lucera | M | 56 |
Triathlon Fund Management LLC
Triathlon Fund Management LLC Investment ManagersFinance Triathlon Fund Management LLC is a hedge fund headquartered in Boston. | 3 years |
W. van Ness | M | 81 | 42 years | |
Jose Carmona | M | 51 | 3 years | |
Martin C. Münchbach | M | 54 | 4 years | |
Elhan Webb | F | - | - | |
Michael Franken | M | 59 | - | |
Gary Hattersley | M | 57 | 15 years | |
Elizabeth Stoner | M | 73 | 4 years | |
Catherine Friedman | F | 63 | 7 years | |
Kurt Graves | M | 56 | 9 years | |
Alan Auerbach | M | 54 | 6 years | |
Jonathan Fleming | M | 66 | 2 years | |
Kim Clarke | M | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 89 | 89.00% |
Ireland | 8 | 8.00% |
United Kingdom | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Owen Hughes
- Personal Network